Eritrea Becomes 34th Country Globally to Eliminate Trachoma
Trachoma is among the 21 diseases and disease groups covered by WHO’s Roadmap for Neglected Tropical Diseases (NTDs) 2021–2030.
Trachoma is among the 21 diseases and disease groups covered by WHO’s Roadmap for Neglected Tropical Diseases (NTDs) 2021–2030.
The two Ebola vaccine candidates are ChAdOx1, developed by the University of Oxford with the Serum Institute of India, and Moderna’s mRNA-1469.
The World Health Assembly will make the final appointment at its 80th session in May 2027, with the new WHO Director-General taking office on 16 August 2027.
The regulator has cautioned that the suspected falsified DEFITELIO Injection could pose serious health risks, including potentially life-threatening consequences.
To support the shift towards community-based mental health care, WHO also released a new guide outlining practical actions for psychiatric hospital leaders to implement deinstitutionalisation.
Seven countries — Angola, Bangladesh, the Democratic Republic of the Congo (DRC), Nigeria, South Sudan, Sudan and Yemen — accounted for around 90% of all reported cholera cases and deaths globally.
Global health workforce shortages: A new WHO report reveals that nearly one in four doctors globally is aged over 55 and is expected to retire within the next decade.
WHO’s prequalification of the multi-dose vial presentation of RSVpreF is expected to make maternal RSV vaccination more affordable and easier to deliver, particularly in countries supported by Gavi.
The framework builds on WHO’s Greener pharmaceuticals’ regulatory highway call to action, launched in 2024.
In eastern Africa, WHO now recommends combining the oral medicine miltefosine with paromomycin injections for treating both kala-azar and post-kala-azar dermal leishmaniasis (PKDL) . In South-East Asia, new combination therapies using liposomal amphotericin B, either alone or together with miltefosine, are recommended for PKDL.